- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Patent holdings for IPC class C12N 15/85
Total number of patents in this class: 12143
10-year publication summary
|
630
|
766
|
1016
|
1020
|
897
|
1020
|
1053
|
1163
|
1106
|
869
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4873 |
407 |
| The Regents of the University of California | 20960 |
229 |
| Massachusetts Institute of Technology | 10322 |
165 |
| The Trustees of the University of Pennsylvania | 4444 |
149 |
| President and Fellows of Harvard College | 6118 |
143 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
113 |
| The Broad Institute, Inc. | 1998 |
105 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 239 |
68 |
| Sangamo Therapeutics, Inc. | 383 |
64 |
| Kymab Limited | 281 |
63 |
| The Johns Hopkins University | 5957 |
62 |
| Duke University | 3190 |
62 |
| The General Hospital Corporation | 4900 |
60 |
| Board of Regents, The University of Texas System | 6187 |
57 |
| Modernatx, Inc. | 1278 |
52 |
| University of Massachusetts | 2340 |
52 |
| Yale University | 2578 |
52 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3024 |
50 |
| Novartis AG | 10170 |
47 |
| The Board of Regents of the University of Texas System | 2315 |
45 |
| Other owners | 10098 |